Evidence map›Paper›PMID 29346682›Full record

ArticleThe Journal of infectious diseases2018

Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding.

Susanna K P Lau, Libiao Zhang, Hayes K H Luk, Lifeng Xiong, Xingwen Peng, Kenneth S M Li, Xiangyang He, Pyrear Su-Hui Zhao, Rachel Y Y Fan, Antonio C P Wong and 11 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04420260 (Scheme of Primary Prevention of Infection by COVID-19, in Workers), which is not on this map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04420260 nacompletednot on this mapstarted 2021, after this paper: background citation

Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia

TypeinterventionalSponsorUnidad de Investigación Genética MolecularRan2021 to 2021Enrolled152ConditionsCOVIDArmsGroup A: oropharygeal spray and immunostimulant emulsion, Group D:Placebo oropharyngeal spray + Placebo taken PO
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Journal of virology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Bats-associated beta-coronavirus detection and characterization: First report from Pakistan.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2023
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Susanna K P LauState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
Libiao ZhangGuangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, and Guangdong Institute of Applied Biological Resources, Guangzhou, Guangdong Province, China.
Hayes K H LukDepartment of Microbiology The University of Hong Kong, China.
Lifeng XiongDepartment of Microbiology The University of Hong Kong, China.
Xingwen PengGuangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, and Guangdong Institute of Applied Biological Resources, Guangzhou, Guangdong Province, China.
Kenneth S M LiDepartment of Microbiology The University of Hong Kong, China.
Xiangyang HeGuangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, and Guangdong Institute of Applied Biological Resources, Guangzhou, Guangdong Province, China.
Pyrear Su-Hui ZhaoDepartment of Microbiology The University of Hong Kong, China.
Rachel Y Y FanDepartment of Microbiology The University of Hong Kong, China.
Antonio C P WongDepartment of Microbiology The University of Hong Kong, China.
Syed Shakeel AhmedDepartment of Microbiology The University of Hong Kong, China.
Jian-Piao CaiDepartment of Microbiology The University of Hong Kong, China.
Jasper F W ChanState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
Yinyan SunNational Institute of Biological Sciences, Zhongguancun Life Science Park, Changping, Beijing, China.
Dongyan JinSchool of Biomedical Sciences, The University of Hong Kong, China.
Honglin ChenState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
Terrence C K LauDepartment of Biomedical Sciences, City University of Hong Kong, China.
Raven K H KokState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
Wenhui LiNational Institute of Biological Sciences, Zhongguancun Life Science Park, Changping, Beijing, China.
Kwok-Yung YuenState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
Patrick C Y WooState Key Laboratory of Emerging Infectious Diseases The University of Hong Kong, China.
University of Hong Kong · HKNational Institute of Biological Sciences, Beijing · CNCity University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although bats are known to harbor Middle East Respiratory Syndrome coronavirus (MERS-CoV)-related viruses, the role of bats in the evolutionary origin and pathway remains obscure. We identified a novel MERS-CoV-related betacoronavirus, Hp-BatCoV HKU25, from Chinese pipistrelle bats. Although it is closely related to MERS-CoV in most genome regions, its spike protein occupies a phylogenetic position between that of Ty-BatCoV HKU4 and Pi-BatCoV HKU5. Because Ty-BatCoV HKU4 but not Pi-BatCoV HKU5 can use the MERS-CoV receptor human dipeptidyl peptidase 4 (hDPP4) for cell entry, we tested the ability of Hp-BatCoV HKU25 to bind and use hDPP4. The HKU25-receptor binding domain (RBD) can bind to hDPP4 protein and hDPP4-expressing cells, but it does so with lower efficiency than that of MERS-RBD. Pseudovirus assays showed that HKU25-spike can use hDPP4 for entry to hDPP4-expressing cells, although with lower efficiency than that of MERS-spike and HKU4-spike. Our findings support a bat origin of MERS-CoV and suggest that bat CoV spike proteins may have evolved in a stepwise manner for binding to hDPP4.

Indexed as

ChiropteraEvolution, MolecularVirus InternalizationAnimalsBetacoronavirusDipeptidyl Peptidase 4HEK293 CellsHumansPhylogenyProtein BindingReceptors, VirusSequence Analysis, DNASpike Glycoprotein, CoronavirusDipeptidyl Peptidase 4DPP4 protein, humanReceptors, VirusSpike Glycoprotein, Coronavirus

Identifiers

PMID29346682
PMCPMC7107427
OpenAlexW2782652855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.